Procter & Gamble (NYSE:PG) PT Raised to $191.00 at Morgan Stanley

Procter & Gamble (NYSE:PG - Get Free Report) had its target price upped by investment analysts at Morgan Stanley from $174.00 to $191.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an "overweight" rating on the stock. Morgan Stanley's price target suggests a potential upside of 12.64% from the company's previous close.

Several other equities analysts have also issued reports on the company. Citigroup lifted their price target on Procter & Gamble from $177.00 to $190.00 and gave the company a "buy" rating in a research note on Wednesday, July 10th. Hsbc Global Res raised shares of Procter & Gamble to a "strong-buy" rating in a report on Friday, October 4th. DZ Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price target on the stock in a report on Thursday, August 29th. Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an "outperform" rating in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a "buy" rating in a research note on Wednesday, July 17th. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $177.00.

Procter & Gamble Price Performance

Shares of NYSE:PG traded down $1.72 during trading on Monday, reaching $169.56. 5,522,260 shares of the company traded hands, compared to its average volume of 6,686,861. The firm has a market capitalization of $400.18 billion, a PE ratio of 27.65, a PEG ratio of 3.74 and a beta of 0.41. Procter & Gamble has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The company's 50 day moving average is $171.77 and its two-hundred day moving average is $167.24.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the prior year, the company posted $1.83 earnings per share. The business's revenue for the quarter was down .6% on a year-over-year basis. As a group, sell-side analysts predict that Procter & Gamble will post 6.97 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO Andre Schulten sold 13,041 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company's stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm's stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company's stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 383,194 shares of company stock worth $65,140,718. Company insiders own 0.17% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Lloyd Advisory Services LLC. raised its position in Procter & Gamble by 493.1% in the 1st quarter. Lloyd Advisory Services LLC. now owns 10,990 shares of the company's stock valued at $1,783,000 after buying an additional 9,137 shares during the last quarter. Traynor Capital Management Inc. raised its holdings in shares of Procter & Gamble by 15.9% in the first quarter. Traynor Capital Management Inc. now owns 6,046 shares of the company's stock valued at $981,000 after purchasing an additional 830 shares during the last quarter. Southland Equity Partners LLC boosted its holdings in Procter & Gamble by 12.5% during the first quarter. Southland Equity Partners LLC now owns 36,858 shares of the company's stock worth $5,980,000 after purchasing an additional 4,087 shares during the last quarter. Global Assets Advisory LLC bought a new stake in Procter & Gamble in the 1st quarter worth about $27,383,000. Finally, Financial Synergies Wealth Advisors Inc. increased its stake in Procter & Gamble by 124.6% in the 1st quarter. Financial Synergies Wealth Advisors Inc. now owns 878 shares of the company's stock valued at $142,000 after buying an additional 487 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.